IB/IIa Study of MG-K10 in Adolescent Moderately Severe Patients

NCT06765005 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: MG-K10

Sponsor

Shanghai Mabgeek Biotech.Co.Ltd